• 한국임상수의학회지
• /
• 제36권6호
• /
• pp.325-329
• /
• 2019

This study was designed to compare the effects of continuous release of an anti-glaucoma drug applied by an osmotic pump and by conventional eye drop instillation in normal beagle dogs, by measuring drug concentration in the blood and monitoring intra-ocular pressure (IOP). In group 1, an osmotic pump filled with Trusopt® was implanted subcutaneously over the right eye of each dog and the IOP was measured. In group 2, the right eye of each dog was administered with 2% dorzolamide (Trusopt®, Merck, USA) three times per day. Blood was sampled once per week in all groups. The IOP of the end of this study was 16.7 ± 0.58 mmHg in group 2 and 17.7 ± 2.52 mmHg in group 2. Dorzolamide concentration in blood increased continuously over 4 weeks up to 585.8 ± 79.42 ㎍/L in group 1, and 747.3 ± 27.89 ㎍/L in group 2. We achieved satisfactory results in the osmotic pump group, which had a similar effect on IOP, and low fluctuations in IOP. Therefore, the results of this study should allow osmotic pumps to be consider as an alternative method to eye drops for the effective, safe, and convenient treatment of glaucoma.

• Journal of Veterinary Science
• /
• 제24권1호
• /
• pp.6.1-6.6
• /
• 2023

Two Shih-Tzu dogs with atopic dermatitis presented with delayed periocular dermatitis (PD) following the instillation of dorzolamide and dorzolamide/timolol combination eyedrops; the development of dermatologic signs took 94 and 104 d in cases 1 and 2, respectively. Hypersensitivity to anti-glaucoma eyedrops was highly suspected, and treatment was discontinued. Delayed PD was significantly relieved in cases 1 and 2, at days 155 and 64 after discontinuation, respectively. In this study, the clinical characteristics and progression of delayed PD were described to inform clinicians who may encounter this rare side effect.

• 대한수의학회지
• /
• 제62권3호
• /
• pp.26.1-26.7
• /
• 2022

This study was aimed to evaluate the prophylactic anti-glaucoma effect of topical 5% betaxolol (BTX) and 2% dorzolamide (DRZ) on the second eye in dogs with unilateral primary angle closure glaucoma (PACG). Medical records of 60 dogs with unilateral PACG who received prophylactic anti-glaucoma eyedrops in the second eye, from 2016 to 2021, were reviewed. The prophylactic effects of BTX were maintained on 28/60 (46.7%) eyes until last visit and BTX failure was observed on median 510 (range, 53-1,927) days in 32/60 (53.3%) eyes. After DRZ instillation in BTX failure eyes, the prophylactic effects were extended at median 610 (range, 157-2,270) days in 21/32 (65.6%) eyes. DRZ failure eyes (17/21, 81.0%) eyes required chemical ablation or surgical intervention due to uncontrolled intraocular pressure. The duration of prophylactic effects was decreased with aging (R² = 0.334, p = 0.006). The predominant breeds were Shih-Tzu (41.9%) and American Cocker Spaniel (30.6%) with no significant differences in survival curves (p = 0.210). The average prophylactic effects of BTX persisted more than 1.5 year and could be selected the first prophylactic eye drop in unilateral PACG. Also, early surgical intervention should be considered in prophylactic medications failure cases.

• 한국산학기술학회논문지
• /
• 제20권2호
• /
• pp.681-693
• /
• 2019

다회용 점안제는 개봉 후 여러 번 사용되기 때문에 사용 중 품질저하 가능성이 높다. 다회용 점안제의 개봉 후 안정성 평가 관련 국내외 규정의 비교분석을 통해 제제별 안정성을 평가하여 개봉 후 안전한 사용기간을 제안하고자 한다. 국내에서 다빈도로 사용중인 다회용 점안제 4종(올로파타딘염산염(Olo), 플루오로메톨론(Flu), 도르졸라미드염산염(Dor), 티몰롤말레산염(Timol))을 대상으로 개봉 후 실제 사용방법에 따른 보관조건을 통해 안정성을 평가하였다. 연구결과 Olo는 개봉 2개월 이후 주성분 및 보존제 함량이 감소하였고, Flu는 개봉 후 28일 차부터 함량이 감소되었다. Dor와 Timol 복합점안제의 경우 Dor은 함량 및 유연물질이 개봉 후 14일부터, Timol의 함량은 개봉 후 28일부터 안정성 저하를 보였다. Olo, Flu은 개봉 후 28일 이내로, Dor, Timol은 개봉 후 14일 이내에만 사용되어야 한다. 무균제제인 다회용 점안제는 개봉 후 안정성 평가를 통해 사용기간 설정에 대한 규제제도 개선이 필요함을 제언하고자 한다.

• Journal of Veterinary Science
• /
• 제24권1호
• /
• pp.16.1-16.11
• /
• 2023

Background: Long-term comparative data of phacoemulsification combined with endoscopic cyclophotocoagulation (phaco-ECP) versus phacoemulsification (phaco) alone in dogs are rare. Objectives: To investigate the effects of ECP on postoperative intraocular pressure (IOP) and complications after phaco in dogs with normal IOP. Methods: Medical records of IOP, conjunctival hyperemia, corneal edema, aqueous flare, posterior synechia, intraocular fibrin, and posterior capsule opacification (PCO) formation in 15 canine eyes that underwent phaco-ECP and 36 eyes that underwent phaco alone were evaluated retrospectively. ECP was applied when either the iridocorneal angle or the ciliary cleft was narrow or closed. Results: The IOP of the phaco-ECP group persisted within the normal range postoperatively. The phaco-ECP group had a shorter period of dorzolamide use than did the phaco group. PCO was formed earlier in the phaco-ECP group than in the phaco group. The phaco-ECP group showed more severe corneal edema than the phaco group at every follow-up visit. Posterior synechia was more severe in the phaco-ECP group than in the phaco group from two weeks until the last follow-up. Conclusions: Although ECP might cause more postoperative complications such as corneal edema and posterior synechia, it could effectively reduce the incidence of IOP increase after phaco in dogs with a high risk of postoperative glaucoma.